CV Lattes
Universidade Estadual de Campinas (UNICAMP). Centro de Biologia Molecular e Engenharia Genética (CBMEG) (Institutional affiliation from the last research proposal) Birthplace: Brazil
graduation at Ciências Biológicas - Bacharelado from Universidade Estadual de Campinas (2009), master's at Genetics from Universidade Estadual de Campinas (2012) and doctorate at Genetics from Universidade Estadual de Campinas (2016). Has experience in Genetics, focusing on Human and Medical Genetics, acting on the following subjects: population genetics, sickle, ancestralidade brasileira, divulgação científica and latinos. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Although sickle cell anemia results from homozygosity for a single mutation at position 6 of gamma-hemoglobin locus, this disease presents high heterogenity in phenotype, so that different patients may have significantly different clinical outcomes. Virtually all organs may be affected by vascular occlusion, with emphasis on the Central Nervous System (CNS), where are observed transient i…
Sickle cell disease are characterized by the presence of hemoglobin S (HbS), which favors the formation of sickled red cells through its polymerization in deoxygenated state. Homozygous individuals for the allele of hemoglobin S are affected by sickle cell anemia, while heterozygotes individuals may develop other sickle cell diseases (especially hemoglobin SC) or on sickle cell trait (Hb)…
Although sickle cell anemia (SCA) results from the homozygosity of a single mutation in amino acid 6 of the ²-globin locus, this disease presents high phenotypic heterogeneity, so that different patients may have significantly different clinical outcomes. Vascular occlusion occurs systemically, and transient ischemic attacks, stroke and cerebral hemorrhage affect approximately 25% of pati…
| 2 / 2 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 3 / 3 | All Scholarships |
| Associated processes | |